IE000KD0BZ68
IE000KD0BZ68
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
Loading chart...
Analytics & Allocation
Detailed breakdown by growth drivers, valuation & quality, and asset allocation
Growth Drivers (Estimates)
Largest contributors to earnings and revenue growth
Sectors & Industries
Weight
Avg. Growth
Contribution
Balance Sheet & Financial Health
Aggregated leverage and valuation structure
Weighted P/E
33.34
Weighted Fwd P/E
82.98
Avg P/FCF
49.98
Avg FCF Yield
0.45%
Avg EV / EBITDA
80.89
Avg EV / Revenue
89.53
Avg Price-to-Book (P/B)
17.15
Avg Price-to-Sales (P/S)
102.24
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
+148.92%
Avg Debt-to-Equity (D/E)
57.06%
<50% (52.43%) 50-150% (37.76%) >150% (3.14%) Unreported (6.67%)
Profitability Analysis
117 Holdings CountProfitable 69.71%
Profitable 69.71%
49
Holdings Count (41.88%)
Unprofitable 30.29%
68
Holdings Count (58.12%)
ETF Concentration (Cumulative Weight)
Cumulative weight of positions (Lorenz curve)
Top 5
24.0%
Top 10
43.7%
Top 25
75.2%
50% Threshold
Top 12
The top 10 positions account for 43.7% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.
Geographic Distribution
12 CountriesLoading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (17.0%+)
High (44.3%+)
Top (61.3%+)
Country Breakdown
Max: 68.16%
US US68.16%
CH CH12.59%
CN CN6.28%
NL NL5.64%
GB GB5.23%
HK HK0.63%
ES ES0.42%
SE SE0.28%
AU AU0.26%
JP JP0.20%
IT IT0.13%
KR KR0.11%
Sector Distribution
3 SectorIndustry Distribution
8 IndustriesMarket Cap Distribution
117 Holdings CountMega Cap (> 200B)
(2) 3.92%
Large Cap (10B - 200B)
(27) 70.12%
Mid Cap (2B - 10B)
(49) 22.54%
Small / Micro Cap (< 2B)
(22) 3.35%
Unclassified
(17) 0.08%